Market Capitalization of Glenmark Pharmaceuticals (GLENMARK)
As of May 27, 2026, Glenmark Pharmaceuticals (GLENMARK) market capitalisation is ₹65950.33 Cr ($7.33B), with 27.65 Cr shares outstanding at a current price of ₹2384.90 on NSE, ranking 164 out of 5361 companies by market cap in our screener. Glenmark Pharmaceuticals operates in the Healthcare sector and is classified as a Large Cap stock. Analyse GLENMARK FII DII holdings to track promoter, FII and institutional holdings.
Market Cap History of Glenmark Pharmaceuticals (Last 10 Years)
GLENMARK market capitalisation from year-end NSE closing prices over the last 10 years. Read Glenmark Pharmaceuticals dividend policy for the complete payout history and dividend yield track record.
End of Year Market Cap History — Glenmark Pharmaceuticals
GLENMARK year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see GLENMARK share price screener.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹65950.33 Cr
$7.33B USD
|
₹2384.90 | NSE | +17.18% |
| 2025 |
₹56279.97 Cr
$6.25B USD
|
₹2035.20 | NSE | +26.48% |
| 2024 |
₹44496.91 Cr
$4.94B USD
|
₹1609.10 | NSE | +88.43% |
| 2023 |
₹23614.53 Cr
$2.62B USD
|
₹853.95 | NSE | +101.33% |
| 2022 |
₹11729.14 Cr
$1.30B USD
|
₹424.15 | NSE | -19.75% |
| 2021 |
₹14616.15 Cr
$1.62B USD
|
₹528.55 | NSE | +7.10% |
| 2020 |
₹13646.90 Cr
$1.52B USD
|
₹493.50 | NSE | +42.03% |
| 2019 |
₹9608.14 Cr
$1.07B USD
|
₹347.45 | NSE | -49.87% |
| 2018 |
₹19165.11 Cr
$2.13B USD
|
₹693.05 | NSE | +16.53% |
| 2017 |
₹16446.79 Cr
$1.83B USD
|
₹594.75 | NSE | -33.06% |
| 2016 |
₹24568.57 Cr
$2.73B USD
|
₹888.45 | NSE | -3.63% |
| 2015 |
₹25493.57 Cr
$2.83B USD
|
₹921.90 | NSE | +19.70% |
| 2014 |
₹21298.56 Cr
$2.37B USD
|
₹770.20 | NSE | +44.27% |
| 2013 |
₹14762.71 Cr
$1.64B USD
|
₹533.85 | NSE | +1.00% |
| 2012 |
₹14616.15 Cr
$1.62B USD
|
₹528.55 | NSE | +80.05% |
| 2011 |
₹8117.62 Cr
$901.96M USD
|
₹293.55 | NSE | -18.93% |
| 2010 |
₹10013.26 Cr
$1.11B USD
|
₹362.10 | NSE | +31.27% |
| 2009 |
₹7628.16 Cr
$847.57M USD
|
₹275.85 | NSE | -6.84% |
| 2008 |
₹8188.14 Cr
$909.79M USD
|
₹296.10 | NSE | -50.32% |
| 2007 |
₹16481.36 Cr
$1.83B USD
|
₹596.00 | NSE | +97.78% |
| 2006 |
₹8333.32 Cr
$925.92M USD
|
₹301.35 | NSE | +92.21% |
| 2005 |
₹4335.48 Cr
$481.72M USD
|
₹156.78 | NSE | +29.34% |
| 2004 |
₹3352.13 Cr
$372.46M USD
|
₹121.22 | NSE | +238.89% |
| 2003 |
₹989.16 Cr
$109.91M USD
|
₹35.77 | NSE | - |